White label ELPA - ClinicalTrials.eu

Study on Edoxaban for Patients with Atrial Fibrillation and Previous Brain Bleeding

Not recruiting

3 1 1 1
Investigated Diseases:
- Haemorrhage intracranial
- Atrial fibrillation
Investigated Drugs:
- Edoxaban
+4
Study of BT-001 and Pembrolizumab for Patients with Advanced Solid Tumors, Including Sarcoma, Merkel Cell Carcinoma, Melanoma, Breast, and Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on Urea for Treating Low Sodium Levels in Patients with Brain Hemorrhage

Not recruiting

2 1
Investigated Diseases:
- Hyponatraemia
- Subarachnoid haemorrhage
Investigated Drugs:
- Urea
Study on Fluconazole for Children and Adolescents with Fungal Infections

Not recruiting

3 1 1 1
Investigated Diseases:
- Fungal infection
Investigated Drugs:
- Fluconazole
Study on Genotype-Guided Treatment with Carbasalate Calcium, Telmisartan, and Rivaroxaban for Patients with Peripheral Arterial Disease

Not recruiting

3 1 1 1
Investigated Diseases:
- Peripheral arterial occlusive disease
Investigated Drugs:
A study comparing [18F]SynVesT-1 and [18F]flortaucipir to measure synaptic density and tau protein levels in patients with Alzheimer’s disease

Not recruiting

2 1 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- (4R)-4-(3-(18F)Fluoranyl-5-Fluorophenyl)-1-[(3-Methylpyridin-4-Yl)Methyl]Pyrrolidin-2-One
- Flortaucipir (18F)
Study of belantamab mafodotin with drug combination for newly diagnosed multiple myeloma patients who cannot receive transplant

Not recruiting

2 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
Study of low-dose radiation therapy combined with paclitaxel and carboplatin in patients with advanced throat and larynx cancer

Not recruiting

2 1 1 1
Investigated Drugs:
- Carboplatin
- Paclitaxel
Study of Dupilumab’s Effect on Airway Mucus in Adults with Severe Asthma

Not recruiting

3 1 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- Dupilumab
Study on the Effectiveness of Osimertinib for Patients with EGFR Mutant Non-Small Cell Lung Cancer Based on TP53 Mutation Status

Not recruiting

3 1 1 1
Investigated Diseases:
- Lung disorder
Investigated Drugs:
- Osimertinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies